Pfizer Limited Sustainability Profile
Pfizer Limited, a subsidiary of the global pharmaceutical giant Pfizer Inc., is headquartered in India and operates extensively across the Asia-Pacific region. Founded in 1849, Pfizer has established itself as a leader in the pharmaceutical industry, focusing on innovative medicines and vaccines that address critical health challenges. The company is renowned for its diverse portfolio, which includes treatments in areas such as oncology, cardiology, immunology, and infectious diseases. Pfizer Limited's commitment to research and development has led to significant breakthroughs, making its products unique in efficacy and safety. With a strong market position, Pfizer Limited has achieved numerous accolades for its contributions to healthcare, including the rapid development of vaccines during public health emergencies. This dedication to improving patient outcomes solidifies its reputation as a trusted name in the pharmaceutical landscape.
DitchCarbon Score
How does Pfizer Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pfizer Limited's score of 11 is lower than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pfizer Limited's reported carbon emissions
In 2024, Pfizer Limited reported total carbon emissions of approximately 8,182,380 kg CO2e in Great Britain, with emissions broken down into Scope 1, Scope 2, and Scope 3 categories. Specifically, Scope 1 emissions were about 786,240 kg CO2e, Scope 2 emissions totalled approximately 599,980 kg CO2e, and Scope 3 emissions accounted for around 6,796,160 kg CO2e. In India, the company reported Scope 1 emissions of about 57,000 kg CO2e and Scope 2 emissions of approximately 2,475,000 kg CO2e. Pfizer Limited has set significant reduction targets for its carbon footprint. The company aims to reduce its carbon emissions per million tablets by 26% from 0.98 tonnes to 0.72 tonnes for both Scope 1 and Scope 2 emissions by the end of 2024. This commitment reflects Pfizer's ongoing efforts to enhance sustainability and reduce its environmental impact. Overall, Pfizer Limited's climate commitments demonstrate a proactive approach to managing carbon emissions, aligning with industry standards and contributing to global climate goals.
How Carbon Intensive is Pfizer Limited's Industry?
How Carbon Intensive is Pfizer Limited's Location?
Pfizer Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Pfizer Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
